(E)-6-Methoxy-N-(4-(3-(3-methoxyphenyl)acryloyl)phenyl)thieno[2,3-b]quinoline-2-carboxamide

ID: ALA4474429

PubChem CID: 155536946

Max Phase: Preclinical

Molecular Formula: C29H22N2O4S

Molecular Weight: 494.57

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1cccc(/C=C/C(=O)c2ccc(NC(=O)c3cc4cc5cc(OC)ccc5nc4s3)cc2)c1

Standard InChI:  InChI=1S/C29H22N2O4S/c1-34-23-5-3-4-18(14-23)6-13-26(32)19-7-9-22(10-8-19)30-28(33)27-17-21-15-20-16-24(35-2)11-12-25(20)31-29(21)36-27/h3-17H,1-2H3,(H,30,33)/b13-6+

Standard InChI Key:  AHCRVXPNTLOVJQ-AWNIVKPZSA-N

Molfile:  

 
     RDKit          2D

 36 40  0  0  0  0  0  0  0  0999 V2000
   30.6061  -18.2052    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.6050  -19.0247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.3130  -19.4337    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.3112  -17.7963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.0198  -18.2016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.0206  -19.0206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.7291  -19.4276    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.7236  -17.7913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4327  -18.1947    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4403  -19.0138    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2216  -19.2597    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   34.6970  -18.5925    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2093  -17.9344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.5141  -18.5848    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9293  -19.2887    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.9161  -17.8733    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   36.7465  -19.2811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.1569  -19.9857    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.9733  -19.9785    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.3761  -19.2664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.9565  -18.5602    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.1415  -18.5710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.1932  -19.2577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.6094  -19.9610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.5943  -18.5456    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   40.4265  -19.9523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.8426  -20.6556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.4405  -21.3648    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.8559  -22.0677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.6740  -22.0594    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.0748  -21.3424    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.6570  -20.6425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.8919  -21.3307    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   43.2904  -20.6173    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8983  -17.7967    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.8981  -16.9795    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7 10  2  0
  9  8  2  0
  8  5  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13  9  1  0
 12 14  1  0
 14 15  1  0
 14 16  2  0
 15 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
 20 23  1  0
 23 24  1  0
 23 25  2  0
 24 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 27  1  0
 31 33  1  0
 33 34  1  0
  1 35  1  0
 35 36  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4474429

    ---

Associated Targets(Human)

MIA PaCa-2 (5949 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PANC-1 (6144 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A-375 (9258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF-10A (2462 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 494.57Molecular Weight (Monoisotopic): 494.1300AlogP: 6.62#Rotatable Bonds: 7
Polar Surface Area: 77.52Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.71CX Basic pKa: 3.85CX LogP: 6.20CX LogD: 6.20
Aromatic Rings: 5Heavy Atoms: 36QED Weighted: 0.20Np Likeness Score: -1.13

References

1. Abdelbaset MS, Abdel-Aziz M, Ramadan M, Abdelrahman MH, Abbas Bukhari SN, Ali TFS, Abuo-Rahma GEA..  (2019)  Discovery of novel thienoquinoline-2-carboxamide chalcone derivatives as antiproliferative EGFR tyrosine kinase inhibitors.,  27  (6): [PMID:30744932] [10.1016/j.bmc.2019.02.012]

Source